„Mercedes“
Suchergebnisse
1.000+ Treffer
-
Obsession - Solange ich dich liebe – Roman - Das große Finale der internationalen Romance-Bestseller-Trilogie für alle Fans von Culpa Mia
-
Liquid Crystal Organization of Calix (4) arene‐Appended Schiff Bases and Recognition towards Zn 2+
-
The HST PanCET Program: Hints of Na i and Evidence of a Cloudy Atmosphere for the Inflated Hot Jupiter WASP-52b
-
Sensibility
-
Femmes sans frontières – Stratégies transnationales féminines face à la mondialisation, XVIIIe-XXIe siècles
-
Mercedes-Benz 170 V/170 S/220 – Bestseller/Retter/Wegbereiter
-
Crashtest Dummies – Roman
-
Lucrecia y Alejandro – un amor inesperado : novela romántica
-
Developmental features of cotton fibre middle lamellae in relation to cell adhesion and cell detachment in cultivars with distinct fibre qualities
-
Longitudinal volumetric and 2D assessment of cerebellar atrophy in a large cohort of children with phosphomannomutase deficiency (PMM2-CDG)
-
Risk factors of non-tuberculous mycobacterial lymphadenitis in children: a case–control study
-
Ecotoxicological characterization of polyoxyethylene glycerol ester non-ionic surfactants and their mixtures with anionic and non-ionic surfactants
-
The steel–concrete interface
-
Does Ethical Leadership Motivate Followers to Participate in Delivering Compassion?
-
Psychosocial Factors in the Relationship between Socioeconomic Status and Cardiometabolic Risk: the HCHS/SOL Sociocultural Ancillary Study
-
Early metallurgy in SE Iberia. The workshop of Las Pilas (Mojácar, Almería, Spain)
-
Anatomical variations of the greater palatine canal in cone-beam computed tomography
-
Mapping the Intellectual Structure of Research on ‘Born Global’ Firms and INVs: A Citation/Co-citation Analysis
-
Developmental trajectories of physical activity and television viewing during adolescence among girls: National Growth and Health Cohort Study
-
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)